Committed to Transforming Human Health
We are a group of life scientists, engineers, and entrepreneurs challenging ourselves and others to create breakthrough biomedical innovation, and make it available to people everywhere.
“The dynamic integration of science, engineering, and design combined with a deep commitment to impact make Vaxess an inspiring place to be.”
Our Leadership
Michael Schrader
Co-founder, CEO
Lynda Tussey, PhD
Chief Development Officer
John Spiridigliozzi
VP of Device Development
Kathryn Kosuda, PhD
Co-Founder, Chief Scientific Officer
Jonathan Kluge, PhD
VP of Research and Development
Weiner Tilsner
Head of Quality and Compliance
Livio Valenti
Co-founder, Senior VP of Strategy, Operations and Business Development
Matthew Dirckx, PhD
VP of Engineering
Board of Directors
Ann Dewitt, PhD
General Partner, The Engine
Michael Schrader
Co-founder, CEO
Mario Barro
Director of Innovation, RA Ventures
Kathryn Kosuda, PhD
Co-Founder, Chief Scientific Officer
Fenel Eloi
Managing Partner, P&M Capital Partners
Advisory Board
Barry Bloom, PhD
Professor of Public Health, Harvard
David Kaplan, PhD
Professor of Engineering, Tufts University
Dennis Giesing, PhD
Chief Scientific Officer, Taris Biomedical
Eve Slater, MD
Former SVP, Pfizer
Robert Mashal
Former Head of Strategy for Inflammation and Oncology, Sanofi
Fiorenzo Omenetto, PhD
Scientific Co-Founder, Advisor
George Siber, MD
Chief Scientific Officer, Clearpath Vaccines Co.
Mark Mckinlay, PhD
Director for The Center for Vaccine Equity At The Task Force for Global Health
Peter Barton Hutt, JD
Senior Council, Covington and Burling
Russell Middaugh, PhD
Professor of Pharmaceutical Chemistry, University of Kansas
Thomas Monath, MD
Managing Partner andnd Chief Scientific Officer, Crozet Biopharma
Vicki Sato, PhD
Former Professor, Harvard Business School And Chairman, Vir Biotechnology
Wayne Pisano
Former President and CEO, Sanofi Pasteur